Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer
Titel:
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer
Auteur:
Price, Timothy Kim, Tae Won Li, Jin Cascinu, Stefano Ruff, Paul Suresh, Attili Satya Thomas, Anne Tjulandin, Sergei Guan, Xuesong Peeters, Marc